Good thing Blarcamesine hopes to treat dementia AND schizophrenia.
And just where do you think AVXL price will be once positive schizophrenia results are posted? And then, just where do you think AVXL price will be once EMA approves Blarcamesine?
I doubt that $9 to $10 is anywhere close to where AVXL price will be with positive schizophrenia results. And when that is coupled with EMA Blarcamesine approval later this year, one might not be too far off in guessing we see triple digits within a fairly short time frame of EMA approval.
I suspect that many market players will be willing to pay $20 or better with positive schizophrenia results and with the high probability of EMA approval, given its superiority in every way to current competition, the recent strengthening in AVXL price is indicative of many market players wanting to get in now before the AVXL price explosion.
Were you excited for Mid 2027 earliest? Two more years.......funny. I hate when people say without the subject. I find women do that more often than men.